RALA and cancer: As already explained above, PPP2R1B also specifically contributes to regulation of a signaling pathway downstream of RAS, by decreasing RalA phosphorylation and activity [63]: thus, decreased PPP2R1B expression may contribute to increased cancer cell migration and EMT-high state.